F

Freenome

468 employees

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Basic info

Industry

biotechnology research

Sectors

computational biology
Biotechnology
molecular diagnostics
biotechnology
Personal Health
early cancer detection
cancer screening
machine learning
oncology
Health Diagnostics
Health Care
multiomics

Date founded

2014

Funding rounds raised

Total raised

$300M

from 46 investors over 46 rounds

F

Freenome raised $300M on December 7, 2021

Investors: Suvretta Capital Management LLC, Pura Vida Investments, Soleus Capital Management, L.P., Section 32, RA Capital Management, L.P., Sands Capital Management, T. Rowe Price and Ridgeback Capital Management LLC

F

Freenome raised $270M on August 26, 2020

Investors: Sands Capital Management, Soleus Capital Management, L.P., Perceptive Advisors, T. Rowe Price, Section 32, Polaris Partners and RA Capital Management, L.P.

F

Freenome raised $160M on July 24, 2019

Investors: T. Rowe Price, RA Capital Management, L.P., Polaris Partners, Verily, Longevity Vision Fund, Soleus Capital Management, L.P., Perceptive Advisors and Section 32

F

Freenome raised $7M on August 28, 2017

Investors: Founders Fund, CRV, Data Collective, Asset Management Ventures, Section 32, S28 Capital, Innovation Endeavors, Polaris Partners, Verily and GV

F

Freenome raised $65M on March 1, 2017

Investors: Founders Fund, Andreessen Horowitz, Asset Management Ventures, GV, Innovation Endeavors, Data Collective, AME Cloud Ventures, Polaris Partners and S28 Capital

F

Freenome raised $5.6M on June 9, 2016

Investors: Founders Fund, Andreessen Horowitz and Data Collective

F

Freenome raised undisclosed on December 1, 2014

Investors: Loxbridge Research

FAQ